ASIC has secured winding up orders against Gold Coas- based ALAMMC Developments and a number of related companies amid concerns the property developer mismanaged millions of investors funds.
The contingency fee rate sought by Shine Lawyers in its bid to vary a group costs order in a class action against EML Payments has been revealed as the percentage profit it initially proposed to a judge, who took an ax to it three years ago.
Animal drug company Zoetis has lost its bid for summary dismissal of claims that it infringed US-based animal genomics company Scidera’s bovine gene patent, with a judge saying its novel arguments were not so clear-cut and needed to be worked out at trial.
The applicants in a case over strip searches conducted of female passengers on a Qatar Airways flight at Doha Airport want the airline to produce any communications with other planes, and to do so by month’s end.
Boroondara City Council has told a court that builder ADCO was “particularly motivated” to not provide a parent company guarantee under a $59 million contract to develop the Kew Recreation Centre after the roof of the building collapsed during the construction.
A prefab home builder has filed an application with the High Court after it was ordered to pay $500,000 in damages for engaging in misleading and deceptive conduct to convince a couple to vary their contract to allow the use of cladding they had previously rejected.
Civil construction firm United Crib Blocks Construction has won a fight over a notice to produce in a case alleging a former employee has misused the company’s confidential information.
Billabong founder Gordon Merchant has won the ear of the High Court in his fight over what the ATO claims was a “wash sale” of his 10 million shares in the retailer, but the justices have also agreed to hear the tax office’s appeal.
A judge has declined car dealer software supplier Pentana’s bid to withdraw admissions made over four years ago in a dispute with competitor Titan DMS.
Samsung Bioepis has successfully opposed Janssen’s bid to patent a monoclonal antibody to treat ulcerative colitis, but an IP Australia delegate has given the J&J-owned company a chance to fix its application.